| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
APC
|
adenomatous polyposis coli
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARRDC3
|
arrestin domain containing 3
|
|
ATP5O
|
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit
|
|
B3GAT3
|
beta-1,3-glucuronyltransferase 3
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CALCOCO1
|
calcium binding and coiled-coil domain 1
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHPF2
|
chondroitin polymerizing factor 2
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHSY3
|
chondroitin sulfate synthase 3
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COMT
|
catechol-O-methyltransferase
|
|
CREM
|
cAMP responsive element modulator
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRX
|
cone-rod homeobox
|
|
CST3
|
cystatin C
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ESR1
|
estrogen receptor 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FNTB
|
farnesyltransferase, CAAX box, beta
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HDAC9
|
histone deacetylase 9
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HK2
|
hexokinase 2
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IRS2
|
insulin receptor substrate 2
|
|
IZUMO1
|
izumo sperm-egg fusion 1
|
|
KDM5D
|
lysine (K)-specific demethylase 5D
|
|
KDR
|
kinase insert domain receptor
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LMNA
|
lamin A/C
|
|
LTA
|
lymphotoxin alpha
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCM6
|
minichromosome maintenance complex component 6
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NAPG
|
N-ethylmaleimide-sensitive factor attachment protein, gamma
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH4
|
notch 4
|
|
NPAS2
|
neuronal PAS domain protein 2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NTF3
|
neurotrophin 3
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PGR
|
progesterone receptor
|
|
PLOD1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1
|
|
PON1
|
paraoxonase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PPP2R5E
|
protein phosphatase 2, regulatory subunit B', epsilon isoform
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PRKCD
|
protein kinase C, delta
|
|
PRL
|
prolactin
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PSCA
|
prostate stem cell antigen
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAD51
|
RAD51 recombinase
|
|
RAX
|
retina and anterior neural fold homeobox
|
|
REN
|
renin
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SLC1A4
|
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRB
|
T cell receptor beta locus
|
|
TYMS
|
thymidylate synthetase
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
ZC3H7B
|
zinc finger CCCH-type containing 7B
|